1.Knoppers B. M. and Chadwick R., “Human genetic research: Emerging trends in ethics,” Nature Review Genetics 2005, 6: 75–79.
4.Homer N., Szelinger S., Redman M., Duggan D., Tembe W., et al. “Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays,” PLoS Genetics, 2008, 4: e1000167..
6.Collins F. S. and McKusick V. A., “Implications of the Human Genome Project for medical science,” JAMA 2001, 285: 540–544.
7.Knoppers B. M., Abdul-Rahman M. H., and Bédard K., “Genomic databases and international collaboration,” KLJ 2007, 18:291–311.
8.M⊘ldrup C., “Ethical, social and legal implications of pharmacogenomics: A critical review,” Community Genetics 2001, 4: 204–214.
11.Sharp R. R. and Foster M. W., “Involving study populations in the review of genetic research,” JLME 2000, 28: 41–51.
13.Regan P. M., Legislating Privacy: Technology, Social Values, and Public Policy (Chapel Hill: University of North Carolina Press, 1995), p. 231.
15.The Quebec Network of Applied Genetic Medicine (RMGA), “Confidentiality” .
17., Church G., Heeney C., Hawkins N., de Vries J., et al., “Public access to genome-wide data: Five views on balancing research with privacy and protection,” PloS Genetics 2009, 5:e1000665. .